FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Amisulpride 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norethisterone 750 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norethisterone 750 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Aspirin 300 mg and codeine 8 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 300 mg and codeine 8 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Aripiprazole 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aripiprazole 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aripiprazole 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aripiprazole 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aripiprazole 30 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Atomoxetine (as atomoxetine hydrochloride) 10 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 18 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Atomoxetine (as atomoxetine hydrochloride) 25 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Bosentan 125 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Modafinil 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Artemether 20 mg and lumefantrine 120 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Artemether 20 mg and lumefantrine 120 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Olmesartan medoxomil 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely nabilone 2 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely nabilone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Nabilone 250 microgram oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Adefovir dipivoxil 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Miglustat 100 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely moxonidine 300 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely aprepitant 80 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Aprepitant 125 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Metoprolol tartrate 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Oxaprozin potassium 600 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cevimeline 30 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 81 mg and pravastatin 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 81 mg and pravastatin 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Aspirin 81 mg and pravastatin 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 81 mg and pravastatin 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Aspirin 81 mg and pravastatin 80 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 81 mg and pravastatin 80 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Aspirin 325 mg and pravastatin 80 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 325 mg and pravastatin 80 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Aspirin 325 mg and pravastatin 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 325 mg and pravastatin 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Aspirin 325 mg and pravastatin 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aspirin 325 mg and pravastatin 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Metformin hydrochloride 625 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Amlodipine besylate 5 mg and atorvastatin 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Amlodipine besylate 5 mg and atorvastatin 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Amlodipine besylate 5 mg and atorvastatin 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Amlodipine besylate 5 mg and atorvastatin 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Amlodipine besylate 5 mg and atorvastatin 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Amlodipine besylate 5 mg and atorvastatin 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Amlodipine besylate 10 mg and atorvastatin 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Amlodipine besylate 10 mg and atorvastatin 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Amlodipine besylate 10 mg and atorvastatin 80 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Amlodipine besylate 10 mg and atorvastatin 80 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Methylphenidate hydrochloride 2.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Naltrexone hydrochloride 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Naltrexone hydrochloride 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Methylene blue 65 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Bisoprolol 2.5 mg and hydrochlorothiazide 6.25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1

Start Previous Page 123 of 217 Next End


This concept is not in any reference sets

Back to Start